B
Vertex Pharmaceuticals Incorporated VRTX
$387.18 -$1.76-0.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 128.74% -41.22% -5.76% 0.98% -492.44%
Total Depreciation and Amortization -4.26% -9.53% -54.87% 26.37% 30.43%
Total Amortization of Deferred Charges -- -- 113.56% -- --
Total Other Non-Cash Items 341.24% 1,522.73% 305.47% 5,314.29% 140.23%
Change in Net Operating Assets 45.15% -307.66% 33.22% -16.62% -198.37%
Cash from Operations 128.59% -37.33% 149.19% 7.99% -430.89%
Capital Expenditure -111.16% 40.50% -59.38% -66.75% -15.77%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 14.16% 99.27% 11.96% -263.55% -61.56%
Cash from Investing -4.49% 97.39% 7.29% -195.67% -52.58%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 90.51% 90.15% 89.17% 52.21% -24.55%
Issuance of Common Stock -10.73% -1.18% -26.08% -45.45% -6.14%
Repurchase of Common Stock 0.77% -91.01% -178.45% -129.96% -1,176.43%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -22.22% -77.14% 160.00% -18.18% -18.18%
Cash from Financing 2.62% -90.32% -226.63% -134.85% -2,172.83%
Foreign Exchange rate Adjustments 2,388.00% 295.51% -272.63% 201.33% -125.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 106.48% 109.41% 9.19% -31.78% -633.74%